Effects of 6-mercaptopurine (NSC-755) in 290 patients with advanced cancer. Eastern Clinical Drug Evaluation Program.
D001943:Breast Neoplasms / Q000188:drug therapy; D002986:Clinical Trials as Topic; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy*; D008545:Melanoma / Q000188:drug therapy; D015122:Mercaptopurine / Q000009:adverse effects* / Q000627:therapeutic use* / Q000633:toxicity*; D009369:Neoplasms / Q000188:drug therapy*
D015122:Mercaptopurine